2H-1-Benzazepin-2-one,1,3,4,5-tetrahydro-3-hydroxy-4-(4-methoxyphenyl)-6-(trifluoromethyl)-, (3R,4S)- (127061-43-2)

Identification
Name:	2H-1-Benzazepin-2-one,1,3,4,5-tetrahydro-3-hydroxy-4-(4-methoxyphenyl)-6-(trifluoromethyl)-, (3R,4S)-
Synonyms:	2H-1-Benzazepin-2-one,1,3,4,5-tetrahydro-3-hydroxy-4-(4-methoxyphenyl)-6-(trifluoromethyl)-,(3R-cis)-; SQ 32191
CAS:	127061-43-2
Molecular Formula:	C18H16 F3 N O3
Molecular Weight:	351.3197
InChI:	InChI=1/C18H16F3NO3/c1-25-11-7-5-10(6-8-11)12-9-13-14(18(19,20)21)3-2-4-15(13)22-17(24)16(12)23/h2-8,12,16,23H,9H2,1H3,(H,22,24)/t12-,16+/m0/s1
Molecular Structure:
Properties
Flash Point:	245.4°C
Boiling Point:	482.1°Cat760mmHg
Density:	1.324g/cm³
Refractive index:	1.547
Flash Point:	245.4°C
Safety Data

Other Product

2H-1-Benzazepin-2-one,1,3,4,5-tetrahydro- 3-hydroxy-4-(4-methoxyphenyl)-6-(trifluoromethyl)-,(3R,4R)-rel-
2H-1-Benzazepin-2-one,1,3,4,5-tetrahydro-3-hydroxy-4-(4-methoxyphenyl)-6-(trifluoromethyl)-, (3S,4R)-
2H-1-Benzazepin-2-one,3-(acetyloxy)-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-1-[2-(methylamino)ethyl]-6-(trifluoromethyl)-,monohydrochloride, (3R,4S)- (9CI)
2H-1-Benzazepin-2-one,3-(acetyloxy)-1-[2-(dimethylamino)ethyl]-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-6-(trifluoromethyl)-,monohydrochloride, (3R,4S)- (9CI)
Benzenepropanamide,4-benzoyl-N-[3-[[2- [(3R,4S)-2,3,4,5-tetrahydro-3-hydroxy-4-(4- methoxyphenyl)-2-oxo-6-(trifluoromethyl)- 1H-1-benzazepin-1-yl]ethyl]amino]propyl]-
2H-1-Benzazepin-2-one,3-(acetyloxy)-1-[2-(dimethylamino)ethyl]-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-7-(trifluoromethyl)-,monohydrochloride, (3R,4S)- (9CI)
3-hydroxy-4-(4-methoxyphenyl)-6-(trifluoromethyl)-1,5-dihydro-2H-1-benzazepin-2-one
2H-1-Benzazepin-2-one,3-(acetyloxy)-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-1-(2-pyrrolidinylmethyl)-6-(trifluoromethyl)-,monohydrochloride, [3R-[1(R*),3a,4a]]- (9CI)
2H-1-Benzazepin-2-one,3-amino-1,3,4,5-tetrahydro-, (3R)-
1H-1-Benzazepin-5-amine,2,3,4,5-tetrahydro-7-methyl-N-(2-methyl-2H-tetrazol-5-yl)-1-(4-pyridinylmethyl)-8-(trifluoromethyl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]-,(5S)-
5,7-Octadien-2-one,1-[(2R,3R,4R,5R,6R)-6-[(1R,2R)-2-(benzoyloxy)-1-[(4-methoxyphenyl)methoxy]propyl]tetrahydro-3,4-bis[(4-methoxyphenyl)methoxy]-5-methyl-2H-pyran-2-yl]-7-chloro-4-hydroxy-, (4S,5E)-
(3S,12aS)-5α-Ethyl-3,3aα,4,5,6,7,8,9,11,12-decahydro-4β-hydroxy-3-methyl-11α-[(2S,4S)-tetrahydro-4-methyl-5-oxofuran-2-yl]-2H-furo[3,2-i]pyrrolo[3,2,1-jk][1]benzazepin-2-one
2H-Pyran-2-one,5-(3,4-dimethoxyphenyl)tetrahydro-3-[(4-hydroxy-3-methoxyphenyl)methyl]-, (3R,5S)-
2H-Pyran-2-one,tetrahydro-4-hydroxy-3-methyl-6-(1-methylethyl)-,(3S,4S,6S)-(9CI)
2,3-Naphthalenedimethanol,1-[2',6-dihydroxy-3',5-dimethoxy-5'-[(2S,3R,4S)-tetrahydro-4-hydroxy-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-(hydroxymethyl)-2-furanyl][1,1'-biphenyl]-3-yl]-1,2,3,4-tetrahydro-3,7-dihydroxy-6-methoxy-,(1S,2S,3S)-
2H-Pyran-2-one,tetrahydro-4-hydroxy-3-methyl-6-(1-methylethyl)-,(3R,4R,6S)-(9CI)
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. with(1S)-1-amino-1,3,4,5-tetrahydro-3-methyl-2H-3-benzazepin-2-one (1:1)
3-(4-fluorophenyl)-1,3,4,5-tetrahydro-1-benzazepin-2-one
(2R)-3-{[{[(2R,3R,4S,5R,6S)-3-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-4-hydroxy-6-methyl-5-({(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)carbamoyl]tetrahydro-2H-pyran-2-yl}oxy)tetrahydro-2H-pyra
(2R)-3-{[{[(2R,3R,4S,5R,6S)-3-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-4-hydroxy-6-methyl-5-({(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)carbamoyl]tetrahydro-2H-pyran-2-yl}oxy)tetrahydro-2H-pyra